Stock

Northrop Grumman Corporation

NOC

Aerospace & Defense · Industrials

Also trades as: 0K92.L GBP 5.49 (-0.65%)

Price

$551.44

-0.91 (-0.16%)

Market Cap

$78.34B

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Oct 23, 2026 · filings through Sep 30, 2026

§How the score breaks down

Quality

Mixed

11/30

Growth

Good

12/20

Cash Flow

Strong

8/10

Stability

Good

6/10

Valuation

Good

6/10

Ownership

Weak

2/15

Dividends

Good

3/5

48 of 100 counted points = Winston Score 48.

Track this stock — start free trial

Share count falling — buybacks

−10.6% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 160.9M (2021) → 143.8M (2025)

§Winston Score History

The full picture

Northrop Grumman builds weapons, aircraft, and technology systems for militaries and governments. Its main products include stealth bombers like the B-21 Raider, missile defense systems, satellites, radar, and cybersecurity tools. The U.S. government is its largest customer by far, making Northrop one of the biggest defense contractors in the world.

The company earns money through long-term government contracts, often worth billions of dollars and lasting many years. It operates primarily in the United States but also sells to allied governments abroad. Its moat comes from being one of only a few companies with the technical expertise and security clearances needed to build complex, classified defense systems — making it very hard for new competitors to enter. The biggest risk is that U.S. defense budget cuts could reduce contract awards, while the key growth driver is rising global demand for advanced defense technology, including space systems and nuclear modernization programs.

Politician Trades

8 trades / 12mo

4 Congressional buys and 4 sells on NOC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.7% YoY

YoY Growth Rate

Slow revenue growth

Reported EPS Growth

+2.9% YoY

Quarterly reporting periods ended:

30 Sept 2025: $7.69

30 Sept 2026: $7.91

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS increased year over year

R&D Spend

$1.1B/ year

→ Flat (+0% vs prior year)

2.6% of revenue

Below sector average (4%)

Steady R&D investment year-over-year

Insider Activity

0.3%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$3.7B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Northrop Grumman Corporation is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

21.1%

Thin — 21.1% gross margin

Profit after running costs

Operating Margin

11.4%

Modest — 11.4% operating margin

Return on the money invested

ROCE

12.4%

Good — 12.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+6.5%

Slow sales growth (+6.5% YoY)

Profit growth

EPS YoY

+14.0%

Earnings growing (+14.0% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

117%

Turns 117% of profit into real cash

Spare cash per sale

FCF Margin

8.8%

Modest free cash flow (8.8%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.89

Moderate — manageable debt (0.89)

Covers its interest

Interest Cover

6.70x

Adequate interest coverage (6.7x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

17.4x

Fair value — P/E 17.4

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year

P/E vs Forward

+2.8

GROWING

Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

2.07%

Moderate income — 2.07% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record

Dividend Growth

+9.4%

Dividend growing modestly (9.4% YoY)

Payout Ratio

30%

no trend

Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial